[Study on the rapid effects of SAMe in primary and secondary triglyceridemias].
A single dose of 30 mg of S-adenosylmethionine was administered to 15 fasting subjects, scrupolously typified, eight of which were affected with primary hypertriglyceridemia, either of type II B or IV according to Fredrickson's classification, and seven with secondary hypertriglyceridemia. Triglyceride and phosphatide concentrations determined 1, 2, 3 and 4 hours after SAMe administration have shown a decrease in blood triglycerides and an increase in phosphatide levels, with significant values for the subjects with the primary form.
D000328:Adult; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D012436:S-Adenosylmethionine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D010743:Phospholipids; D014280:Triglycerides; D012436:S-Adenosylmethionine
Studio degli effetti rapidi della SAMe nelle ipertrigliceridemie primitive e secondarie